80R8139 UM-D
 
  By: Zaffirini S.B. No. 894
 
 
 
   
 
 
A BILL TO BE ENTITLED
AN ACT
relating to enrollment and participation in certain research
programs of certain children in foster care.
       BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
       SECTION 1.  Section 266.001, Family Code, as added by
Chapter 268, Acts of the 79th Legislature, Regular Session, 2005,
is amended by adding Subdivisions (2-a) and (4-a) to read as
follows:
             (2-a)  "Drug research program" means any clinical
trial, clinical investigation, drug study, or active medical or
clinical research regarding:
                   (A)  an investigational new drug; or
                   (B)  the efficacy of an approved drug.
             (4-a)  "Investigational new drug" has the meaning
assigned by 21 C.F.R. Section 312.3(b).
       SECTION 2.  Subchapter A, Chapter 266, Family Code, as added
by Chapter 268, Acts of the 79th Legislature, Regular Session,
2005, is amended by adding Section 266.0041 to read as follows:
       Sec. 266.0041.  ENROLLMENT AND PARTICIPATION IN CERTAIN
RESEARCH PROGRAMS. (a) Notwithstanding Section 266.004, a person
may not authorize the enrollment of a foster child or consent to the
participation of a foster child in a drug research program without a
court order as provided by this section.
       (b)  Before issuing an order authorizing the enrollment or
participation of a foster child in a drug research program, the
court must:
             (1)  appoint an independent medical advocate;
             (2)  review the report filed by the independent medical
advocate regarding the advocate's opinion and recommendations
concerning the foster child's enrollment and participation in the
drug research program; and
             (3)  determine whether enrollment and participation in
the drug research program is in the foster child's best interest.
       (c)  An independent medical advocate appointed under
Subsection (b) is not a party to the suit but may:
             (1)  conduct an investigation regarding the foster
child's participation in a drug research program to the extent that
the advocate considers necessary to determine the best interest of
the child for whom the advocate is appointed; and
             (2)  obtain and review copies of the foster child's
relevant medical and psychological records and information
describing the risks and benefits of the child's enrollment and
participation in the drug research program.
       (d)  An independent medical advocate shall, within a
reasonable time after the appointment, interview:
             (1)  the foster child in a developmentally appropriate
manner, if the child is four years of age or older;
             (2)  the medical team treating the foster child as well
as the medical team conducting the drug research program; and
             (3)  each individual who has significant knowledge of
the foster child's medical history and condition, including any
foster parent of the child.
       (e)  After reviewing the information collected under
Subsections (c) and (d), the independent medical advocate shall:
             (1)  submit a report to the court presenting the
advocate's opinion and recommendation regarding whether the foster
child's best interest is served by enrollment and participation in
the drug research program; and
             (2)  at the request of the court, testify regarding the
basis for the advocate's opinion and recommendation concerning the
foster child's enrollment and participation in a drug research
program.
       (f)  The court may appoint any person eligible to serve as
the foster child's guardian ad litem as the independent medical
advocate, except that a foster parent, representative of the
department, medical professional affiliated with the drug research
program, or any person the court determines has a conflict of
interest may not serve as the foster child's independent medical
advocate.
       (g)  A person otherwise authorized to consent to medical care
for a foster child may petition the court for an order permitting
the enrollment and participation of a foster child in a drug
research program under this section.
       SECTION 3.  The change in law made by this Act by the
enactment of Section 266.0041, Family Code, applies only to the
enrollment and participation of a foster child in a drug research
program on or after the effective date of this Act. A foster child
enrolled or participating in a drug research program before the
effective date of this Act is governed by the law in effect when the
foster child was enrolled or began participating in the drug
research program, and the former law is continued in effect for that
purpose.
       SECTION 4.  This Act takes effect September 1, 2007.